Tandem Diabetes Care Inc
NASDAQ:TNDM
Tandem Diabetes Care Inc
NASDAQ:TNDM
Price:
47.82 USD
0.95%
Market Closed
Updated:
May 16, 2024
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
-22.7
Current
-5.7
Median
12.9
Industry
Lower
than median
Lower
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=-22.7
Enterprise Value
/
3B
EBITDA
-130.7m
All Countries
| Market Cap | EV/EBITDA | ||||
|---|---|---|---|---|---|
| US |
|
Tandem Diabetes Care Inc
NASDAQ:TNDM
|
3.1B USD | -22.7 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
182.2B USD | 19.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
140.8B USD | 58.2 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127.3B USD | 24.6 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
113.8B USD | 14.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
109.6B USD | 31.2 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
68.2B USD | 18.7 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
60.6B EUR | 19.1 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
54.4B USD | 28 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
378.2B CNY | 28.6 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
52.2B USD | 61 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
1 621.7
2-Years Forward
EV/EBITDA
71.4
3-Years Forward
EV/EBITDA
44.3
You don't have any saved screeners yet
